(Reuters) – Bayer AG is in mediation to potentially settle thousands of U.S. lawsuits claiming that the company’s Roundup weed killer causes cancer, but some…View More Explainer: What are the obstacles to Bayer settling Roundup lawsuits?
(Reuters) – Elanco Animal Health (ELAN.N) agreed to buy Bayer’s (BAYGn.DE) veterinary drugs unit on Tuesday in a cash and stock deal valued at $7.6…View More Elanco to become No.2 in animal health with $7.6 billion Bayer deal
FRANKFURT (Reuters) – Shares in German chemicals company Bayer (BAYGn.DE) rose 2.8% in early trading in Frankfurt on Tuesday after a U.S. judge slashed a…View More Bayer shares up 2.8% in early Frankfurt trade after U.S. Roundup rule
FRANKFURT (Reuters) – Three of Bayer’s largest German investors said the drugmaker’s embattled management needed to stay at the helm to avoid further upheaval, despite…View More Investors call for reprieve for Bayer bosses after AGM rebuke
FRANKFURT (Reuters) – One of Bayer’s largest shareholders tore into the company’s management on Wednesday for underestimating the legal risks of its takeover of Monsanto,…View More Bayer shareholder Deka joins chorus of complaints over Monsanto
(Reuters) – A federal judge overseeing lawsuits alleging Bayer AG’s glyphosate-based weed killer causes cancer has issued a ruling that could severely restrict evidence that…View More U.S. judge limits evidence in trial over Roundup cancer claims